Eura sells MYL 50.71: Teva and Mylan Settle Copaxone Patent Litigation in France, the UK and the Netherlands
Teva Pharmaceutical Industries (NYSE:TEVA) and Mylan Inc. (NASDAQ:MYL) today announce that certain of their affiliates have agreed to settle and dismiss pending patent litigation involving Copaxone (glatiramer acetate) in the United Kingdom, the ... ...
44 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home